Corporate News 06-Jun-17
Board of Advanced Enzyme Techs. recommends final dividend
Of Rs 0.4 per share
Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting held on 27 May 2017, inter alia, have recommended the final dividend of Rs 0.4 per equity Share (i.e. 20%) , subject to the approval of the shareholders.
Previous News
Advanced Enzyme Technologies
( Results - Analysis 12-Aug-20 19:55 )
Volumes spurt at Sundaram Clayton Ltd counter
( Hot Pursuit - 09-Jun-20 14:30 )
Volumes soar at Advanced Enzyme Technologies Ltd counter
( Hot Pursuit - 25-Feb-22 14:30 )
Advanced Enzyme Techs. schedules AGM
( Corporate News - 08-Jul-23 17:36 )
Advanced Enzyme Technologies consolidated net profit rises 99.79% in the September 2016 quarter
( Results - Announcements 14-Nov-16 17:55 )
Advanced Enzyme Tech gains after Q3 PAT rises 52% YoY
( Hot Pursuit - 12-Feb-24 10:39 )
Advanced Enzyme Technologies standalone net profit rises 349.52% in the September 2016 quarter
( Results - Announcements 14-Nov-16 17:07 )
Advanced Enzyme Techs. schedules board meeting
( Corporate News - 13-May-22 15:53 )
Advanced Enzyme Technologies
( Results - Analysis 01-Jun-20 13:59 )
Advanced Enzyme Techs. to hold board meeting
( Corporate News - 07-Nov-16 14:06 )
Advanced Enzyme Technologies awarded as “The Best Nutraceutical Company of the Year”
( Corporate News - 24-Nov-16 19:15 )
Other Stories
Anmol India to conduct board meeting
03-Oct-24 10:07
KPI Green Energy receives CEIG approval for 5 MW solar power project
03-Oct-24 10:04
Navkar Corporation revises board meeting date
03-Oct-24 09:52
Paytm deploys card machines across 2 Krishi Mandis in Madhya Pradesh
03-Oct-24 09:52
Adani Ports records 14% growth in cargo volumes in September 2024
03-Oct-24 09:37
SignatureGlobal India launches new project in Gurugram
03-Oct-24 09:34
Biocon Biologics refinances debt through USD bonds and syndicated term loan
03-Oct-24 09:29
RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
03-Oct-24 09:26
Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
03-Oct-24 09:23
Transformers & Rectifiers India wins order of Rs 565 cr
03-Oct-24 09:07
Back
Top